Prosarix Overview
- Founded
- 2006
- Status
- Acquired/Merged
- Latest Deal Type
- M&A
- Financing Rounds
- 1
Prosarix General Information
Description
Owner and operator of a biotechnology company. The company is engaged in developing computational approaches and products to assist in various aspects of drug discovery.
Contact Information
Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Parent Company
Evolva Holding
Primary Office
- Newton Hall, Town Street
- Newton
- Cambridge CB22 7ZE
- England, United Kingdom
+44 01223 000000
Prosarix Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Prosarix‘s full profile, request access.
Request a free trialProsarix Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| William Hamilton Ph.D | Chief Executive Officer | ||
| Jonathan Heal Ph.D | Chief Scientific Officer | ||
| Joe Sheridan Ph.D | Director of Drug Discovery |